Serum NF-κB p105 and IL-17 in psoriasis: associations with disease status and severity

Nazlı Caf, Naile Fevziye Mısırlıoglu, Seyma Dumur, Burcu Biltekin, Göknur Özaydın Yavuz, Erişcan Melih Kırsoy, Hafize Uzun

Open source

DOI
10.1080/15569527.2026.2748320
Published
2026-10-15
Container
Cutaneous and Ocular Toxicology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/15569527.2026.2748320,
  title = {Serum NF-κB p105 and IL-17 in psoriasis: associations with disease status and severity},
  author = {Nazlı Caf and Naile Fevziye Mısırlıoglu and Seyma Dumur and Burcu Biltekin and Göknur Özaydın Yavuz and Erişcan Melih Kırsoy and Hafize Uzun},
  year = {2026},
  journal = {Cutaneous and Ocular Toxicology},
  doi = {10.1080/15569527.2026.2748320},
  url = {https://doi.org/10.1080/15569527.2026.2748320}
}

RIS

TY  - JOUR
TI  - Serum NF-κB p105 and IL-17 in psoriasis: associations with disease status and severity
AU  - Nazlı Caf
AU  - Naile Fevziye Mısırlıoglu
AU  - Seyma Dumur
AU  - Burcu Biltekin
AU  - Göknur Özaydın Yavuz
AU  - Erişcan Melih Kırsoy
AU  - Hafize Uzun
PY  - 2026
JO  - Cutaneous and Ocular Toxicology
DO  - 10.1080/15569527.2026.2748320
UR  - https://doi.org/10.1080/15569527.2026.2748320
ER  - 

APA

Caf, N., Mısırlıoglu, N. F., Dumur, S., Biltekin, B., Yavuz, G. Ö., Kırsoy, E. M., & Uzun, H. (2026). Serum NF-κB p105 and IL-17 in psoriasis: associations with disease status and severity. Cutaneous and Ocular Toxicology. https://doi.org/10.1080/15569527.2026.2748320

Source records